SUSMED,Inc.

Tokyo Stock Exchange 4263.T

SUSMED,Inc. Price to Sales Ratio (P/S) on January 14, 2025: 31.32

SUSMED,Inc. Price to Sales Ratio (P/S) is 31.32 on January 14, 2025, a 12.65% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • SUSMED,Inc. 52-week high Price to Sales Ratio (P/S) is 36.15 on September 02, 2024, which is 15.42% above the current Price to Sales Ratio (P/S).
  • SUSMED,Inc. 52-week low Price to Sales Ratio (P/S) is 20.44 on August 05, 2024, which is -34.74% below the current Price to Sales Ratio (P/S).
  • SUSMED,Inc. average Price to Sales Ratio (P/S) for the last 52 weeks is 29.95.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Tokyo Stock Exchange: 4263.T

SUSMED,Inc.

CEO Mr. Taro Ueno
IPO Date Dec. 24, 2021
Location Japan
Headquarters MFPR Nihonbashi honcho Bldg
Employees 39
Sector Health Care
Industries
Pharmaceuticals Mobile Apps Smartphones
Description

SUSMED,Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

StockViz Staff

January 15, 2025

Any question? Send us an email